Howard Lee

Howard Lee has led the SōRSE team since 2016, which to date has tripled in size. He has brought SōRSE to the international marketplace through licensing agreements with The Valens Company and FCM Global and into the medical space through a cancer research partnership with Pascal Biosciences.

Howard brings over 20 years of leadership experience in the tech industry and enterprise world, having served as CEO and founder of multiple start-ups where he was responsible for raising seed funding; Series A, B, C funding; and growth equity rounds.